Leif Rogers MD FACS Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Leif Rogers MD FACS's estimated annual revenue is currently $2.3M per year.(i)
  • Leif Rogers MD FACS's estimated revenue per employee is $162,000

Employee Data

  • Leif Rogers MD FACS has 14 Employees.(i)
  • Leif Rogers MD FACS grew their employee count by -12% last year.

Leif Rogers MD FACS's People

NameTitleEmail/Phone
1
Director Media and Content Creation, Patient Coordinator, Events CoordinatorReveal Email/Phone
2
Aesthetic NurseReveal Email/Phone
3
NurseReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M5-81%N/AN/A
#2
$17M70-4%N/AN/A
#3
$4.9M264%N/AN/A
#4
$10.2M4718%N/AN/A
#5
$0.7M5-92%N/AN/A
#6
$66.2M2239%N/AN/A
#7
$12.6M5227%N/AN/A
#8
$53.2M179-2%N/AN/A
#9
$5.1M27-10%N/AN/A
#10
$22.1M824%N/AN/A
Add Company

What Is Leif Rogers MD FACS?

Leif Rogers, MD, FACS in Beverly Hills and Pasadena, California is dedicated to upholding the highest quality standards in reconstructive surgery, cosmetic plastic surgery, and non-surgical aesthetics, to include an optimal balance of artistry with the most sophisticated medical advances. Our commitment to quality extends into every interaction of our patient experience to deliver the level of excellence we ourselves expect from a world-renowned medical practice. By closely connecting with our patients' needs and desires, LRMD identifies the most suitable surgical and non-surgical options that resolve every unique face and body issue, thereby promoting self-confidence.

keywords:N/A

N/A

Total Funding

14

Number of Employees

$2.3M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Leif Rogers MD FACS News

2022-03-22 - What to Know About QWO, the Injectable Cellulite Treatment

To break down what you need to know before getting QWO, we spoke to Leif Rogers, MD, FACS, a board-certified plastic and reconstructive...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A14-67%N/A
#2
N/A1440%N/A
#3
$1.2M1427%N/A
#4
$2.3M14-7%N/A
#5
N/A1440%N/A